The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
Abstract
Background The intercellular adhesion molecule ICAM-1 mediates adhesion and transmigration of leucocytes to the vascular endothelial wall, a step proposed to be critical in the initiation and progression of atherosclerosis. Whether concentrations of soluble ICAM-1 (sICAM-1) are raised in apparently healthy individuals who later suffer acute myocardial infarction is unknown.Methods We obtained baseline plasma samples from a prospective cohort of 14,916 healthy men enrolled in the Physicians' Health Study. With a nested case-control design, we measured sICAM-1 concentrations for 474 participants who developed a first myocardial infarction, and 474 controls (participants who remained healthy throughout the 9-year follow-up). Cases were matched to controls according to age and smoking status at the time of myocardial infarction.Findings We found a significant association between increasing concentration of sICAM-1 and risk of future myocardial infarction (p = 0.003), especially among participants with baseline sICAM-1 concentrations in the highest quartile (> 260 ng/mL; relative risk 1.6 [95% Cl 1.1-2.4], p = 0.02). This association was present overall as well as among non-smokers, and persisted after control for lipid and non-lipid risk factors. In multivariate analyses, the risk of future myocardial infarction was 80% higher for participants with baseline sICAM-1 concentrations in the highest quartile (relative risk 1.8 [1.1-2.8], p = 0.02). Similar risk estimates were seen among non-smokers. We found slight but significant correlations between sICAM-1 and fibrinogen, high-density-lipoprotein cholesterol, homocysteine, triglycerides, tissue-type plasminogen-activator antigen, and C-relative protein, but adjustment for these altered the risk little. The risk of myocardial infarction associated with raised concentrations of sICAM-1 seemed to increase with length of follow-up.Interpretation Our data support the hypothesis that cellular mediators of inflammation have a role in atherogenesis and provide a clinical basis to consider antiadhesion therapies as a novel means of cardiovascular disease prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“sICAM-1 has been shown to be associated with increased risk of future nonfatal cardiovascular events and incident diabetes. 37,38”
From Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide (2026) · cites this paper as [37]
Citations
Cites
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Adhesion receptors of the immune system
Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Endothelial Expression of a Mononuclear Leukocyte Adhesion Molecule During Atherogenesis
Cybulsky, M. I., & Gimbrone, M. A. (1991) · Science · doi:10.1126/science.1990440 · Cited by 1,710
Pober, J. S., Gimbrone, M. A., Lapierre, L. A., Mendrick, D. L., Fiers, W., Rothlein, R., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.6.1893 · Cited by 1,413
Davies, M. J., Gordon, J. L., Gearing, A. J. H., Pigott, R., Woolf, N., Katz, D. R., & Kyriakopoulos, A. (1993) · The Journal of Pathology · doi:10.1002/path.1711710311 · Cited by 777
Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650
Cited by
Sorted by citations
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Self-citationRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Self-citationMiddleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
“artery disease (Ridker et al., 1998).”
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
“In obese women, a yearlong program of low fat diet and exercise reduced plasma levels of tumor necrosis factoralpha, interleukin-6, soluble ICAM-1, and soluble vascular cell adhesion molecule-1 (VCAM-1) (52).”
BackgroundInfluentialCurrent Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,575
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B., Davis, A., Lockshin, M. D., Sammaritano, L. R., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,422
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Wood, D., Backer, G. D., Færgeman, O., Graham, I. D., Mancia, G., & Pyörälà, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,253
Adhesion molecules and atherosclerosis
Blankenberg, S., Barbaux, S., & Tiret, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00097-2 · Cited by 1,098
“[83] Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J.”
BackgroundResultInfluentialZiccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 930
Lopez-Garcia, E., Schulze, M. B., Fung, T. T., Meigs, J. B., Rifai, N., Manson, J. E., & Hu, F. B. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.4.1029 · Cited by 881
“Higher concentrations of E-selectin and sICAM-1 have been observed in patients with ischemic heart disease (23), and baseline plasma concentrations of sICAM-1 are predictors of myocardial infarction in apparently healthy men (24).”
BackgroundStress, inflammation and cardiovascular disease
Black, P. H., & Garbutt, L. D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00302-6 · Cited by 812
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 756
Blood Pressure and Inflammation in Apparently Healthy Men
Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 718
Inflammatory bio‐markers and cardiovascular risk prediction
Blake, G., & Ridker, P. M. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01019.x · Cited by 699
ICAM-1 signaling in endothelial cells
Lawson, C., & Wolf, S. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70004-0 · Cited by 685
“A significant correlation between sICAM-1 concentrations and future coronary artery disease has been demonstrated by several groups [34, 55, 71], but refuted by others [70].”
ResultCushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., & Tracy, R. P. (1999) · Circulation · doi:10.1161/01.cir.100.7.717 · Cited by 660
“Hysterectomy, yes 20 (28) 20 (27) 18 (25) 18 (24) 20 (27)”
Lopez-Garcia, E., Schulze, M. B., Meigs, J. B., Manson, J. E., Rifai, N., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.3.562 · Cited by 600
“, patients with coronary heart disease had higher levels of E-selectin and sICAM-1 (23), and baseline plasma levels of sICAM-1 were predictors of myocardial infarction among apparently healthy men (24).”
BackgroundAccelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
Doornum, S. V., McColl, G., & Wicks, I. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10089 · Cited by 606
Acute Systemic Inflammation Impairs Endothelium-Dependent Dilatation in Humans
Hingorani, A. D., Cross, J. M., Kharbanda, R. K., Mullen, M. J., Bhagat, K., Taylor, M., Donald, A. E., Palacios‐Callender, M., Griffin, G. E., Deanfield, J. E., et al. (2000) · Circulation · doi:10.1161/01.cir.102.9.994 · Cited by 605
Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease
Blankenberg, S., Rupprecht, H. J., Bickel, C., Peetz, D., Hafner, G., Tiret, L., Meyer, J., & for the AtheroGene Investigators (2001) · Circulation · doi:10.1161/hc3701.095949 · Cited by 595
Soluble P-Selectin and the Risk of Future Cardiovascular Events
Ridker, P. M., Buring, J. E., & Rifai, N. (2001) · Circulation · doi:10.1161/01.cir.103.4.491 · Cited by 564
Nappo, F., Esposito, K., Cioffi, M., Giugliano, G., Molinari, A. M., Paolisso, G., Marfella, R., & Giugliano, D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01741-2 · Cited by 555
“Soluble forms of cellular adhesion found in plasma are considered an index of endothelial activation and even a molecular marker of early atherosclerosis (15).”
BackgroundAnti-inflammatory therapies for cardiovascular disease
Ridker, P. M., & Lüscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu203 · Cited by 568
“Epidemiological data have long shown strong positive associations betweensoluble levels of these adhesionmolecules and futurevascular events and thus multiple adhesion molecules serve as potential vasculoprotective targets for atherothrombosis.(61)”
BackgroundHigh-Sensitivity C-Reactive Protein: A Novel and Promising Marker of Coronary Heart Disease
Rifai, N., & Ridker, P. M. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.403 · Cited by 518
Placental Debris, Oxidative Stress and Pre-eclampsia
Redman, C. W. G., & Sargent, I. L. (2000) · Placenta · doi:10.1053/plac.2000.0560 · Cited by 508
Heavy Metal Poisoning and Cardiovascular Disease
Alissa, E. M., & Ferns, G. A. (2011) · Journal of Toxicology · doi:10.1155/2011/870125 · Cited by 511
“predictive for CVD [85].”
Endothelial Dysfunction in Chronic Inflammatory Diseases
Steyers, C. M., & Miller, F. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150711324 · Cited by 498
“Efforts to define plasma biomarkers for endothelial dysfunction have largely focused on soluble intercellular adhesion molecules (CAMs), including intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule (VCAM-1), E-selectin and others [20,21].”
BackgroundHigh-sensitivity C-reactive protein
Bassuk, S. S., Rifai, N., & Ridker, P. M. (2004) · Current Problems in Cardiology · doi:10.1016/s0146-2806(04)00074-x · Cited by 493
Immunomodulation and Anti-Inflammatory Effects of Garlic Compounds
Arreola, R., Quintero-Fabián, S., López-Roa, R. I., Flores-Gutiérrez, E. O., Reyes‐Grajeda, J. P., Carrera-Quintanar, L., & Ortuño‐Sahagún, D. (2015) · Journal of Immunology Research · doi:10.1155/2015/401630 · Cited by 477
“Among these are markers of systemic inflammation, such as high-sensitivity C-reactive protein (CRP), and acute-phase protein [91], serum amyloid A, cytokines such as IL-6, and adhesion molecules such as soluble intercellular adhesion molecule type 1 (ICAM-1) [92, 93] and vascular cell adhesion molecule-1 (VCAM-1) [94].”
BackgroundAssessment and treatment of endothelial dysfunction in humans
Anderson, T. J. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00259-4 · Cited by 443
“predictive of future myocardial infarction (20).”
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 420
Chalmers, J. D., Smith, M. P., McHugh, B. J., Doherty, C., Govan, J. R. W., & Hill, A. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0487oc · Cited by 408
“These findings may have relevance beyond airway inflammation because raised levels of endothelium-derived inflammatory markers (particularly ICAM-1) have been linked to an increased frequency of myocardial infarction (32), stroke (33), and diabetes (34), which are increased in patients with chronic lung disease, in ad…”
BackgroundNF-κB Inhibition Ameliorates Angiotensin II–Induced Inflammatory Damage in Rats
Müller, D. N., Dechend, R., Mervaala, E. M. A., Park, J.-K., Schmidt, F. H., Fiebeler, A., Theuer, J., Breu, V., Ganten, D., Haller, H. G., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.193 · Cited by 402
Ageing, tumour necrosis factor-alpha (TNF- α ) and atherosclerosis
Brüünsgaard, H., Skinhøj, P., Pedersen, B. K., Schroll, M., & Pedersen, B. K. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01281.x · Cited by 407
ABO Blood Group and the Risk of Pancreatic Cancer
Wolpin, B. M., Chan, A. T., Hartge, P., Chanock, S. J., Kraft, P. L., Hunter, D. J., Giovannucci, E. L., & Fuchs, C. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp020 · Cited by 406
Relation between markers of systemic vascular inflammation and smoking in women
Bermudez, E. A., Rifai, N., Buring, J. E., Manson, J. E., & Ridker, P. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02284-1 · Cited by 385
Malik, I. S., Danesh, J., Whincup, P. H., Bhatia, V. K., Papacosta, O., Walker, M., LENNON, L. T., Thomson, A. G., & Haskard, D. O. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06104-9 · Cited by 383
Cellular adhesion molecules and atherogenesis
Price, D. T., & Loscalzo, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00153-9 · Cited by 388
Pathogenesis of atherosclerosis: A multifactorial process.
Singh, R. B., Mengi, S. A., Xu, Y., Arneja, A. S., & Dhalla, N. S. (2002) · PubMed Central · Cited by 382
López‐García, E., Schulze, M. B., Manson, J. E., Meigs, J. B., Albert, C. M., Rifai, N., Willett, W. C., & Hu, F. B. (2004) · Journal of Nutrition · doi:10.1093/jn/134.7.1806 · Cited by 381
“Higher levels of E-selectin and sICAM-1 were also observed in patients with coronary heart disease (37), and baseline plasma levels of sICAM-1 are predictors of myocardial infarction among apparently healthy men (38).”
BackgroundInflammation and Atherosclerosis
Hartman, J., & Frishman, W. H. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000021 · Cited by 378
Novel Inflammatory Markers of Coronary Risk
Libby, P., & Ridker, P. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1148 · Cited by 375
Circulating markers of inflammation and atherosclerosis
Lind, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00012-1 · Cited by 373
“[59] Ridker PM, Hennekens CH, Roitman-Johnson B, et al.”
BackgroundInflammatory Markers and the Metabolic Syndrome
Koh, K. K., Han, S. H., & Quon, M. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.06.082 · Cited by 374
Ceriello, A., Quagliaro, L., Piconi, L., Assaloni, R., Da Ros, R., Maier, A., Esposito, K., & Giugliano, D. (2004) · Diabetes · doi:10.2337/diabetes.53.3.701 · Cited by 362
“Soluble forms of some cellular adhesion molecules can be found in plasma, and it has been suggested that elevated plasma levels of some cellular adhesion molecules may be an index of endothelial activation (6) or even a molecular marker of early atherosclerosis (7).”
BackgroundKoga, H., Sugiyama, S., Kugiyama, K., Watanabe, K., Fukushima, H., Tanaka, T., Sakamoto, T., Yoshimura, M., Jinnouchi, H., & Ogawa, H. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.047 · Cited by 362
Dietary modulation of endothelial function: implications for cardiovascular disease
Brown, A. A., & Hu, F. B. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.4.673 · Cited by 352
Balagopal, P., de Ferranti, S. D., Cook, S., Daniels, S. R., Gidding, S. S., Hayman, L. L., McCrindle, B. W., Mietus‐Snyder, M., & Steinberger, J. (2011) · Circulation · doi:10.1161/cir.0b013e31821c7c64 · Cited by 363
Arsenic and Cardiovascular Disease
States, J. C., Srivastava, S., Chen, Y., & Barchowsky, A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn236 · Cited by 359
“Circulating markers of systemic inflammation and endothelial dysfunction such as soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1) are predictive for CVD (Blankenberg et al., 2001; Hwang et al., 1997; Ridker et al., 1998, 2000).”
Anti-inflammatory and immunomodulatory effects of statins
Blanco‐Colio, L. M., Tuñón, J., Martı́n-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 347
Paré, G., Chasman, D. I., Kellogg, M., Zee, R. Y. L., Rifai, N., Badola, S., Miletich, J. P., & Ridker, P. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000118 · Cited by 341
“Finally, plasma concentration of sICAM-1 has been shown to provide unique predictive value for the risk of myocardial infarction (MIM 608446), ischemic stroke (MIM 601367), peripheral arterial disease (MIM 606787) and noninsulin-dependent diabetes mellitus (MIM 125853) in epidemiological studies [5–7].”
BackgroundSelf-citationHamdy, O., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., Moussa, A., Caselli, A., Caballero, A. E., Economides, P. A., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2119 · Cited by 340
“Circulating soluble adhesion molecules are valuable markers of atherosclerosis, and particularly the elevated sICAM levels were found to be associated with increased risk of future myocardial infarction in healthy men (26).”
Montagnani, M., Golovchenko, I., Kim, I., Koh, G. Y., Goalstone, M. L., Mundhekar, A. N., Johansen, M. L., Kucik, D. F., Quon, M. J., & Draznin, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103728200 · Cited by 332
Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1
Ohga, E., Tomita, T., Wada, H., Yamamoto, H., Nagase, T., & Ouchi, Y. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00177.2002 · Cited by 328
“Moreover, the circulating ICAM-1 level may indicate a risk of future myocardial infarction, suggesting that antiadhesion therapies can be considered as a novel therapeutic means of cardiovascular disease (26).”
BackgroundSavoia, C., & Schiffrin, E. L. (2007) · Clinical Science · doi:10.1042/cs20060247 · Cited by 326
Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?
Ridker, P. M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00018 · Cited by 323
Prostaglandins, Leukotrienes and Essential Fatty Acids
Kaur, G., Sinclair, A. J., Cameron‐Smith, D., Barr, D. P., Molero, J. C., & Konstantopoulos, N. (2009) · Cited by 321
Lespérance, F., Frasure‐Smith, N., Théroux, P., & Irwin, M. R. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.271 · Cited by 305
Inflammatory Markers and Sleep Disturbance in Major Depression
Motivala, S. J., Sarfatti, A., Olmos, L., & Irwin, M. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000149259.72488.09 · Cited by 286
“Prospective data further indicate that sICAM and IL-6, directly implicated in atherosclerotic disease processes, predict risk for myocardial infarction independent of cholesterol levels, smoking status, and obesity (53,54).”
BackgroundThies, F., Miles, E. A., Nebe‐von‐Caron, G., Powell, J. R., Hurst, T. L., Newsholme, E. A., & Calder, P. C. (2001) · Lipids · doi:10.1007/s11745-001-0831-4 · Cited by 279
“The plasma concentrations of these molecules are elevated during inflammatory conditions (2), increase with age (3‐5), are higher in individuals with cardiovascular disease (3,5,6), and are predictive of future myocardial infarction ( 7 ).”
BackgroundCirculating markers of endothelial function in cardiovascular disease
Constans, J., & Conri, C. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.030 · Cited by 282
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
Tham, D. M., Martin-McNulty, B., Wang, Y.-X., Wilson, D. W., Vergona, R. A., Sullivan, M. E., Dole, W. P., & Rutledge, J. C. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2002 · Cited by 279
Plasma tumour necrosis factor-α and early carotid atherosclerosis in healthy middle-aged men
Skoog, T. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2805 · Cited by 278
“That the plasma concentration of the soluble form of at least one cellular adhesion molecule, intercellular adhesion molecule type-1 (sICAM-1), is in fact elevated several years before the occurrence of clinical manifestations of coronary artery disease was recently demonstrated in two prospective epidemiological stud…”
Zouridakis, E., y, P. A., Arroyo‐Espliguero, R., Fredericks, S., & Kaski, J. C. (2004) · Circulation · doi:10.1161/01.cir.0000142664.18739.92 · Cited by 274
Estruch, R., Sacanella, E., Badı́a, E., Antúnez, E., Nicolas, J. M., Fernández‐Solà, J., Rotilio, D., de Gaetano, G., Rubin, E., & Urbano-Márquez, A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.03.006 · Cited by 269
“Although high concentrations of some soluble cellular adhesion molecules are associated with an increased risk of vascular events [21–23], no data are available on clinical conditions or interventions associated with reduced levels of these molecules.”
BackgroundAnticytokine Agents: Targeting Interleukin Signaling Pathways for the Treatment of Atherothrombosis
Ridker, P. M. (2019) · Circulation Research · doi:10.1161/circresaha.118.313129 · Cited by 260
Self-citationNappo, F. (1999) · JAMA · doi:10.1001/jama.281.22.2113 · Cited by 270
“Soluble forms of cellular adhesion molecules found in plasma are considered an index of endothelial activation and even a molecular marker of early atherosclerosis.(26)”
BackgroundDoupis, J., Lyons, T. E., Wu, S., Gnardellis, C., Dinh, T., & Veves, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2385 · Cited by 272
Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration
Evans, J. R., & Lawrenson, J. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000253.pub4 · Cited by 279
Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome
Ohga, E., Nagase, T., Tomita, T., Teramoto, S., Matsuse, T., Katayama, H., & Ouchi, Y. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.1.10 · Cited by 265
“Moreover, the circulating ICAM-1 level may indicate a risk of future myocardial infarction, suggesting that antiadhesion therapies can be considered as a novel therapeutic means to treat cardiovascular disease (22).”
BackgroundRohde, L. E. P., Lee, R. T., Rivero, J., Jamacochian, M., Arroyo, L. H., Briggs, W. H., Rifai, N., Libby, P., Creager, M. A., & Ridker, P. M. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.11.1765 · Cited by 260
“Finally, prospective data from a large cohort of apparently healthy men indicate that elevated baseline levels of sICAM-1 are associated with increased future myocardial infarction.(30) Circulating levels of VCAM-1 have been associated with the extent of clinical atherosclerosis as measured angiographically in patient…”
BackgroundInflammatory Markers of Coronary Risk
Rader, D. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431609 · Cited by 262
López‐García, E., van Dam, R. M., Qi, L., & Hu, F. B. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.4.888 · Cited by 257
“All these molecules have been found to predict cardiovascular disease (27) and to be associated with cardiovascular events (28, 29).”
BackgroundTotal homocysteine and cardiovascular disease
Nygard, O. K., Vollset, S. E., Refsum, H., Brattström, L. E., & Ueland, P. M. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00512.x · Cited by 256
Calder, P. C. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100710 · Cited by 255
“sICAM-1 concentration was shown to be an independent predictor of coronary heart disease [7,8].”
BackgroundBeyond High-Density Lipoprotein Cholesterol Levels
deGoma, E. M., deGoma, R. L., & Rader, D. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.016 · Cited by 252
“Expression of adhesion molecules represents a ynamic process, activated by inflammatory cytokines (53) nd vascular injury (54) and up-regulated in atherosclerosis n both animals (55) and humans (56,57).”
BackgroundPastore, L., Tessitore, A., Martinotti, S., Toniato, E., Alesse, E., Bravi, M. C., Ferri, C., Desideri, G., Gulino, A., & Santucci, A. (1999) · Circulation · doi:10.1161/01.cir.100.15.1646 · Cited by 249
Brinkworth, G. D., Noakes, M., Keogh, J. B., Luscombe, N. D., Wittert, G. A., & Clifton, P. M. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802617 · Cited by 245
Koh, K. K., Cardillo, C., Bui, M. N., Hathaway, L., Csákó, G., Waclawiw, M. A., Panza, J. A., & Cannon, R. O. (1999) · Circulation · doi:10.1161/01.cir.99.3.354 · Cited by 244
PREMATURE ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Bruce, I. N., Gladman, D. D., & Urowitz, M. B. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70138-1 · Cited by 240
Ledue, T. B., & Rifai, N. (2003) · Clinical Chemistry · doi:10.1373/49.8.1258 · Cited by 238
Coronary heart disease risk: Low-density lipoprotein and beyond
Shaya, G. E., Leucker, T. M., Jones, S. R., Martin, S. S., & Toth, P. P. (2021) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.04.002 · Cited by 247
Maßberg, S., Enders, G. A., Matos, F. C. D. M., Tomic, L. I. D., Leiderer, R., Eisenmenger, S., Meßmer, K., & Krombach, F. (1999) · Blood · doi:10.1182/blood.v94.11.3829 · Cited by 241
Wang, T. J., Nam, B., Wilson, P. W. F., Wolf, P. A., Levy, D. A., Polak, J. F., D’Agostino, R. B., & O’Donnell, C. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000034543.78801.69 · Cited by 236
Empana, J. P., Sykes, D. H., Luc, G., Juhan-Vague, I., Arveiler, D., Ferrières, J., Amouyel, P., Bingham, A., Montaye, M., Ruidavets, J., et al. (2005) · Circulation · doi:10.1161/01.cir.0000164203.54111.ae · Cited by 235
ABO Blood Group and Risk of Coronary Heart Disease in Two Prospective Cohort Studies
He, M., Wolpin, B. M., Rexrode, K. M., Manson, J. E., Rimm, E. B., Hu, F. B., & Qi, L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.248757 · Cited by 246
The metabolic syndrome and cardiovascular disease
Bonora, E. (2006) · Annals of Medicine · doi:10.1080/07853890500401234 · Cited by 233
High Density Lipoproteins (HDL) Interrupt the Sphingosine Kinase Signaling Pathway
Xia, P., Vadas, M. A., Rye, K., Barter, P. J., & Gamble, J. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33143 · Cited by 235
Soluble intercellular adhesion molecule-1 (sICAM-1): an overview.
Witkowska, A. M., & Borawska, M. H. (2004) · PubMed · Cited by 231
Chin, K., Nakamura, T., Shimizu, K., Mishima, M., Nakamura, T., Miyasaka, M., & Ohi, M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00580-5 · Cited by 229
High-Density Lipoprotein and Coronary Heart Disease
Natarajan, P., Ray, K. K., & Cannon, C. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.008 · Cited by 231
Pradhan, A. D., Rifai, N., & Ridker, P. M. (2002) · Circulation · doi:10.1161/01.cir.0000025636.03561.ee · Cited by 226
Gomes, M. S., Blattner, T. C., Filho, M. S., Grecca, F. S., Hugo, F. N., FOUAD, A. F., & Reynolds, M. A. (2013) · Journal of Endodontics · doi:10.1016/j.joen.2013.06.014 · Cited by 238
Circulating Adhesion Molecules in Humans
Marfella, R., Esposito, K., Giunta, R. E., Coppola, G., Angelis, L. D., Farzati, B., Paolisso, G., & Giugliano, D. (2000) · Circulation · doi:10.1161/01.cir.101.19.2247 · Cited by 221
Ridker, P. M., Kundsin, R. B., Stampfer, M. J., Poulin, S. A., & Hennekens, C. H. (1999) · Circulation · doi:10.1161/01.cir.99.9.1161 · Cited by 215
Burger, D. E., & Touyz, R. M. (2012) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.11.003 · Cited by 221
“Moreover, in the Physician’s Health Study, high plasma levels of soluble ICAM were associated with a risk of future myocardial infarction, although this was not true of soluble VCAM1 levels.(72,73) C-reactive protein, a protein found in plasma that rises in response to inflammation, is an independent predictor of abno…”
Background
Metadata
- Authors
- Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- R&D Systems (United States) (US)
- Corresponding author
- Ridker, Paul M
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1998-01
- Volume
- 351
- Issue
- 9096
- Pages
- 88-92
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2138809584
- Cited by
- 1,229
- References
- 35
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 16 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 28 · 2016: 27 · 2015: 25 · 2014: 38 · 2013: 27 · 2012: 36
- FWCI
- 26.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- soluble intercellular adhesion molecule-1, sICAM-1, myocardial infarction, atherosclerosis, inflammation, endothelial cell adhesion, anti-adhesion therapy, cardiovascular risk, fibrinogen, homocysteine, tissue plasminogen activator, C-reactive protein, healthy men, Physicians' Health Study
- MeSH terms
- Antioxidants, Arteriosclerosis, Aspirin, Double-Blind Method, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Aggregation Inhibitors, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Intercellular Adhesion Molecule-1, beta Carotene
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review